Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-775-5 | CAS number: 110-52-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: The acute oral toxicity dose (LD50) was considered based on different studies conducted on rats and mice for the test chemical. The LD50 value is between 300 -2000 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified for acute oral toxicity category 4.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 28/08/1986 to 16/10/1986
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- Data is from study report.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Qualifier:
- according to guideline
- Guideline:
- other: EWG Directive 84/449/EWG
- Principles of method if other than guideline:
- Acute oral toxicity study with test chemical in rats.
- GLP compliance:
- not specified
- Test type:
- other: No data
- Limit test:
- no
- Species:
- rat
- Strain:
- other: KFM-Han. Wistar
- Remarks:
- (outbred, SPF-Quality)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Kleintierfarm Madoerin AG,
CH 4414 Fuellinsdorf / Switzerland
- Age at study initiation: 9 to 13 weeks old
- Weight at study initiation: Animals were weighed as follows - Males: 190 - 263 g; Females: 179 - 222 g
- Fasting period before study: The rats were fasted for 12 to 18 hours.
- Housing: Groups of 5 in Makrolon type-3 cages with standard softwood bedding
- Diet (e.g. ad libitum): Pelleted standard Kuba 343, Batch 50/86 rat maintenance diet, ad libitum.
- Water (e.g. ad libitum): Community tap water from Itingen, ad libitum.
- Acclimation period: At least one week under laboratory conditions, after veterinary examination.
ENVIRONMENTAL CONDITIONS
- Temperature (°C):22±3°C
- Humidity (%):relative humidity 40-70 %
- Air changes (per hr): Air-conditioned with 10-15 air changes per hour.
- Photoperiod (hrs dark / hrs light): 12 hours artificial fluorescent light/12 hours dark, music/light period.
IN-LIFE DATES: From: August 21, 1986 To: October 16, 1986 - Route of administration:
- oral: gavage
- Vehicle:
- CMC (carboxymethyl cellulose)
- Remarks:
- 4 % solution of CMC carboxymethylcellulose sodium salt in distilled water
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: Group 1: 10 ml at 100 mg/kg; Group 2: 10 ml at 400 mg/kg;
Group 3: 10 ml at 1000 mg/kg; Group 4: 20 ml at 5000 mg/kg.
DOSAGE PREPARATION (if unusual): The test article was placed into a glass beaker on a tared Mettler PK 4800 balance, and the vehicle (4 % solution of CMC, carboxymethylcellulose sodium salt in distilled water) was added. A weight by volume dilution was prepared using a homogenizer. - Doses:
- 100, 400, 1000 and 5000 mg/kg
- No. of animals per sex per dose:
- Total = 40 (sex/dose)
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 15 days
- Frequency of observations and weighing: Mortality was observed 4 times during test day 1, and daily during days 2-15; and weighing: Test days 1 (pre-administration), 8 and 15 day.
- Necropsy of survivors performed: yes, all animals surviving to the end of the observation period were killed by intraperitoneal injection of sodium pentobarbitone.
- Other examinations performed: Each animal was examined for changes in appearance and behavior 4 times during day 1, and daily during days 2-15. All abnormalities were recorded. The animals were checked for the symptoms like - General Behavior, respiration, body posture, motor susceptibility, motility, etc. - Statistics:
- The LOGIT-Model was applied to estimate the toxicity value. Additionally, the 90, 95 and 99% confidence intervals for the toxicity for each sex and the slope of the dose response line were estimated.
- Preliminary study:
- No data
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 473 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 311 - <= 889
- Remarks on result:
- other: 50% mortality was observed
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 454 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 227 - <= 1 582
- Remarks on result:
- other: 50% mortality was observed
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 454 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- >= 227 - <= 1 582
- Remarks on result:
- other: 50% mortality was observed
- Mortality:
- Mortality was observed as follows – In males – At 400 mg/kg: 1 animal was died.
At 1000 mg/kg: All animals were died.
At 5000 mg/kg: All animals were died.
In Females – At 400 mg/kg: 1 animal was died. At 1000 mg/kg: All animals were died. At 5000 mg/kg: All animals were died. - Clinical signs:
- other: The following symptoms were observed: At 100 mg/kg: sedation, ataxia, curved body position, ruffled fur; At 400 mg/kg: sedation, chromodacryorrhea, ataxia, curved body position, ruffled fur; At 1000 mg/kg: sedation, dyspnea, ataxia, curved body position,
- Gross pathology:
- The following macroscopic organ changes were observed: At 100 mg/kg: no pathologic changes (10).
At 400 mg/kg: lung - discolored, dark-red (1); thymus - discolored, dark-red (1); stomach - meteorism, totally filled (1); p1eura1 cavity - watery, clear fluid (1ml) (1); skin, abdominal cavity - red to brown, yellowish, partly exfoliation, diameter 7mm (1); cannibalism - whole animal (1); no pathologic changes (8).
At 1000 mg/kg: lung - pale (1); dark-red (7); foam excretion (1); several foci, diameter 2mm (2); liver - dark-red (2); stomach - meteorism (2); intestines - meteorism (1);
no pathologic changes (2).
At 5000 mg/kg: lung - dark-red, black foci (1); reddish (6); right, dark-red foci (1); dark-red (1); liver - black (5); spleen - black (5); stomach - meteorism (1); pleural cavity - watery, clear, fluid, (1ml). - Other findings:
- No data
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 was considered to be 473 mg/kg bw in both Males/Females with a 95 % confidence interval of 311 - 889 mg/kg bw; 454 mg/kg with 95 % confidence interval of 227 - 1582 mg/kg in males; and 454 mg/kg ith 95 % confidence interval of 227 - 1582 mg/kg in females, when KFM-Han. Wistar rats were treated with test chemical via oral gavage route.
- Executive summary:
Acute oral toxicity test was conducted according to OECD Guidelines No. 401 “Acute Oral Toxicity" and EWG Directive 84/449/EWG, using test chemical in 40 male and female KFM-Han. Wistar (outbred, SPF-Quality) rats at the concentration of 100, 400, 1000 and 5000 mg/kg bw. The test substance (Purity >96%) was placed into a glass beaker on a tared Mettler PK 4800 balance, and the vehicle (4 % solution of CMC, carboxymethylcellulose sodium salt in distilled water) was added. A weight by volume dilution was prepared using a homogenizer and administered by oral gavage route at the concentration in vehicle as: Group 1: 10 ml at 100 mg/kg; Group 2: 10 ml at 400 mg/kg; Group 3: 10 ml at 1000 mg/kg; Group 4: 20 ml at 5000 mg/kg. Mortality was observed 4 times during test day 1, and daily during days 2-15; and weighing: Test days 1 (pre-administration), 8 and 15 day. All animals surviving to the end of the observation period were killed by intraperitoneal injection of sodium pentobarbitone. Each animal was examined for changes in appearance and behavior 4 times during day 1, and daily during days 2-15. All abnormalities were recorded. The animals were checked for the symptoms like - General Behavior, respiration, body posture, motor susceptibility, motility, etc.The LOGIT-Model was applied to estimate the toxicity value. Additionally, the 90, 95 and 99% confidence intervals for the toxicity for each sex and the slope of the dose response line were estimated.Mortality was observed as - In males – At 400 mg/kg: 1 animal was died. At 1000 mg/kg: All animals were died. At 5000 mg/kg: All animals were died. In Females – At 400 mg/kg: 1 animal was died. At 1000 mg/kg: All animals were died. At 5000 mg/kg: All animals were died. The symptoms were observed in animals as: At 100 mg/kg: sedation, ataxia, curved body position, ruffled fur; At 400 mg/kg: sedation, chromodacryorrhea, ataxia, curved body position, ruffled fur; At 1000 mg/kg: sedation, dyspnea, ataxia, curved body position, ruffled fur; At 5000 mg/kg: sedation, somnolence, rales, chromodacryorrhea, ataxia, latero-abdominal, position, curved body position, ruffled furventral body position (females). All surviving rats had recovered within 4 to 5 observation days. Therefore, LD50 was considered to be 473 mg/kg bw in both Males/Females with a 95 % confidence interval of 311 - 889 mg/kg bw; 454 mg/kg with 95 % confidence interval of 227 - 1582 mg/kg in males; and 454 mg/kg ith 95 % confidence interval of 227 - 1582 mg/kg in females, when KFM-Han. Wistar rats were treated with test chemical via oral gavage route.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 473 mg/kg bw
- Quality of whole database:
- Data is K1 and from study report
Additional information
Acute Oral Toxicity:
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats and mice for test chemical. The studies are summarized as below –
Acute oral toxicity test was conducted according to OECD Guidelines No. 401 “Acute Oral Toxicity" and EWG Directive 84/449/EWG, using test chemical in 40 male and female KFM-Han. Wistar (outbred, SPF-Quality) rats at the concentration of 100, 400, 1000 and 5000 mg/kg bw. The test substance (Purity >96%) was placed into a glass beaker on a tared Mettler PK 4800 balance, and the vehicle (4 % solution of CMC, carboxymethylcellulose sodium salt in distilled water) was added. A weight by volume dilution was prepared using a homogenizer and administered by oral gavage route at the concentration in vehicle as: Group 1: 10 ml at 100 mg/kg; Group 2: 10 ml at 400 mg/kg; Group 3: 10 ml at 1000 mg/kg; Group 4: 20 ml at 5000 mg/kg. Mortality was observed 4 times during test day 1, and daily during days 2-15; and weighing: Test days 1 (pre-administration), 8 and 15 day. All animals surviving to the end of the observation period were killed by intraperitoneal injection of sodium pentobarbitone. Each animal was examined for changes in appearance and behavior 4 times during day 1, and daily during days 2-15. All abnormalities were recorded. The animals were checked for the symptoms like - General Behavior, respiration, body posture, motor susceptibility, motility, etc.The LOGIT-Model was applied to estimate the toxicity value. Additionally, the 90, 95 and 99% confidence intervals for the toxicity for each sex and the slope of the dose response line were estimated.Mortality was observed as - In males – At 400 mg/kg: 1 animal was died. At 1000 mg/kg: All animals were died. At 5000 mg/kg: All animals were died. In Females – At 400 mg/kg: 1 animal was died. At 1000 mg/kg: All animals were died. At 5000 mg/kg: All animals were died. The symptoms were observed in animals as: At 100 mg/kg: sedation, ataxia, curved body position, ruffled fur; At 400 mg/kg: sedation, chromodacryorrhea, ataxia, curved body position, ruffled fur; At 1000 mg/kg: sedation, dyspnea, ataxia, curved body position, ruffled fur; At 5000 mg/kg: sedation, somnolence, rales, chromodacryorrhea, ataxia, latero-abdominal, position, curved body position, ruffled furventral body position (females). All surviving rats had recovered within 4 to 5 observation days. Therefore, LD50 was considered to be 473 mg/kg bw in both Males/Females with a 95 % confidence interval of 311 - 889 mg/kg bw; 454 mg/kg with 95 % confidence interval of 227 - 1582 mg/kg in males; and 454 mg/kg ith 95 % confidence interval of 227 - 1582 mg/kg in females, when KFM-Han. Wistar rats were treated with test chemical via oral gavage route.
In a Single dose acute oral toxicity study, Crj:CD(SD)IGS male and female rats were treated with test chemical in the concentration of 0, 500, 800, 1300, 2000 mg/kg for male and 0, 800, 1300 mg/kg for female orally by gavage in Corn oil. All the male and female rats died at 1300 and 2000 mg/ kg bw as compared to control. Salivation, decrease in locomotor activity, a prone position and ataxic gait were observed in treated rats as compared to control. Decreased body weight gain and/or depressed body weight was observed on the second day in 800 mg/ kg bw treated male and female rats as compared to control. Insufficient retraction and dark red areas in the lung and pale discoloration of the spleen were observed in dead animals and Pulmonary edema and atrophy of the spleen were observed in treated rats. Therefore,LD50 was considered to be between 1300 and 2000 mg/kg for male and between 800 and 1300 mg/kg for female rats when Crj:CD(SD)IGS male and female rats were treated with test chemical orally by gavage.
In a acute oral toxicity study,Crj:CD(SD)IGS male and female rats were treated with test chemical in the concentration of 0, 300, 500, 900, 1500 mg/kg orally by gavage in corn oil. Deaths were observed between days 1 and 3 after administration in male and female rats at 900 and 1500 mg/kg and in female rats 500 mg/kg, at as compared to control. Salivation in all treated groups and lacrimation in the 500, 900 and 1500 mg/kg were observed in both sexes. In addition, decreased spontaneous movement, abnormal gait, adoption of a prone or lateral position and oligopnea were also evident in some animals which died of either sex. All clinical signs observed in the survivors disappeared by day 1 after the administration.When treated with Suppression of gain or decrease of body weights was observed in both sexes in 500, 900 and 1500 mg/kg, mg/kw, but this had disappeared by day 10 after administration in males and day 3 after administration in female. Therefore,LD50 was considered to be 734 mg/kg bw for male and 671 mg/kg bw for female when Crj:CD(SD)IGS male and female rats were treated with test chemical orally by gavage in corn oil.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is is between 300-2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified as "Acute oral toxicity Category 4" according to CLP regulation.
Justification for classification or non-classification
Based on the above studies on test chemical, it can be concluded that LD50 value is between 300 -2000 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified for acute oral toxicity and comes under "Category 4".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.